Are Executives Confident In Maze Therapeutics Maze Stock Price At 28.71 Down 1.17 20260402 BeyondSpring BYSI Q1 2026 Results Meet Expectations Revenue NA NYSE Marks 234th Anniversary with Focus on Evolution and Modernization CNG Prices in Delhi NCR Surge 1 per Litre Second Increase in 48 Hours to Impact Commuters G7 Finance Ministers Convene in Paris Amid Soaring Borrowing Costs and Strait of Hormuz Risk Retail Investors Increase Stakes in Vedanta MCX Among Top 10 Stocks in Q4 China Calls for APEC Trade Cooperation as Commerce Minister Skips Opening Due to Urgent Official Business Divorce at 60 The Retirement Cost of Keeping the Family Home The Fed May Need to Raise Rates in July to Calm Bond Vigilantes Yardeni Warns Safepoint Insurance Targets 116 Billion Valuation in US IPO Fed Dissenters Explain No Votes Questioning Signal of Potential Rate Cut IVR Q1 2026 Earnings Slight EPS Miss Amid Stable Operating Environment DBD Q1 2026 Earnings EPS Beats Estimates Shares Rise on Profitability Strength KBR Q1 2026 Earnings EPS Surpasses Estimates as Government Services Segment Drives Growth ARVN Q1 2026 Earnings NarrowerThanExpected Loss Provides Positive Signal Amid Pipeline Progress RYAM Q1 2026 Earnings Significant EPS Miss Overshadowed by Modest Stock Gain BEPJ Edges Higher as Perpetual Preferred Note Shows Resilience at 2499 Arbor Realty Trust ABR Slides 296 as Support Levels Come into Focus Axsome Therapeutics AXSM Holds Steady Near Resistance as Bullish Momentum Continues Phoenix Asia Holdings PHOE Edges Higher as Key Resistance Nears